Key Insights

Highlights

Success Rate

80% trial completion

Published Results

20 trials with published results (12%)

Research Maturity

71 completed trials (43% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

10.8%

18 terminated out of 166 trials

Success Rate

79.8%

-6.8% vs benchmark

Late-Stage Pipeline

9%

15 trials in Phase 3/4

Results Transparency

28%

20 of 71 completed with results

Key Signals

20 with results80% success18 terminated

Data Visualizations

Phase Distribution

123Total
Not Applicable (49)
Early P 1 (2)
P 1 (29)
P 2 (28)
P 3 (10)
P 4 (5)

Trial Status

Completed71
Unknown39
Recruiting19
Terminated18
Not Yet Recruiting9
Active Not Recruiting6

Trial Success Rate

79.8%

Benchmark: 86.6%

Based on 71 completed trials

Clinical Trials (166)

Showing 20 of 20 trials
NCT07227012Phase 1Recruiting

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

NCT07377487Not ApplicableRecruitingPrimary

TheraSphere Japan Pre-Market Study

NCT07642336Not ApplicableCompletedPrimary

Erector Spinae Plane Block Versus Thoracic Epidural Analgesia for Open Liver Resection

NCT07830576Recruiting

Multimodal Survival Prediction Model for Colorectal Liver Metastases Post-Operation

NCT06486454RecruitingPrimary

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

NCT07811453Not ApplicableNot Yet Recruiting

Liver Transplantation for Non-Resectable Colorectal Liver Metastases Without Local Treatment Options

NCT07727759Recruiting

CT Volumetry and Hepatic Vascular Deformation Mapping to Predict Post-Hepatectomy Liver Failure

NCT07745153CompletedPrimary

Novel Abdominal Compression Positioning Technique for Respiratory Motion Management in Liver Tumors

NCT07745790Phase 2Not Yet Recruiting

Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic Cancer

NCT07719933CompletedPrimary

Intraoperative Continuous Terlipressin Infusion is Associated With Reduced Severe Postoperative Complications After Laparoscopic Hepatectomy: a Prospective Propensity Score-matched Cohort Study

NCT07726329Phase 2Active Not RecruitingPrimary

Dendritic Cell-immunotherapy for Advanced Hepatocellular Carcinoma

NCT04634357Phase 1Recruiting

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

NCT04962958Phase 2Completed

Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

NCT07225114Phase 2Recruiting

Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging

NCT07630610Not ApplicableNot Yet RecruitingPrimary

Feasibility and Safety of Augmented Reality (AR) in Liver Tumor Surgery

NCT07581730Not Yet RecruitingPrimary

A Subharmonic-Aided Pressure Estimate Technology for Prediction of Response to Systemic Therapy in Gastric Cancer Liver Metastases

NCT07583381Not ApplicableNot Yet Recruiting

A Prospective Study of a Subharmonic-Aided Pressure Estimate Technology for Early Prediction of Response to Systemic Therapy in Colorectal Cancer Liver Metastases

NCT06794073Not ApplicableRecruiting

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

NCT07556835Not Yet RecruitingPrimary

Outcomes After Liver and Biliary Resection at a High-Volume Center

NCT07192172Not ApplicableCompleted

Enhanced Radiofrequency Ablation for Recurrent HCC Post-TACE Using Twin Internally Cooled-Perfusion Electrodes

Scroll to load more

Research Network

Activity Timeline